2V
Verastem, Inc.
2VSA.F · FSX
6.58 € +2.91% (+0.19 €)
1M +8.49%
Market Cap $643.7M
P/E Ratio -
Div. Yield -
ROE 468.00%
Piotroski F-Score Moderate
4/9Valuation
6 /100
Expensive P/S 7.36x
P/B 12.88x
P/E N/A
Growth
91 /100
Growing Rev. growth 128.36%
Book val. growth 6.47%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 86.69%
FCF margin 185.24%
Net margin 231.61%
Quality
5 /100
Poor ROIC 119.33%
Asset turnover 0.42x
ROE 468.00%
Debt
36 /100
Moderate Debt/Equity 1.69x
Int. coverage -147.99x
Current ratio 2.25x
Stability
38 /100
Moderate Beta 0.29x
Profitable years 0
EPS volatility 30.48%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 2VSA.F
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Daniel W. Paterson
Employees
102
Headquarters
Needham
Upcoming events
03 NOV
Earnings
Upcoming earnings report